Verwendung: Dieses Produkt ist ausschließlich für Forschungszwecke bestimmt.
Alle Produktinformationen auf dieser Website dienen ausschließlich Bildungszwecken. Jede Form der Einbringung in den Körper von Menschen oder Tieren ist gesetzlich streng verboten. Dieses Produkt darf nur von zugelassenen und qualifizierten Fachleuten gehandhabt werden. Es ist kein Arzneimittel, Lebensmittel oder Kosmetikum und darf nicht als solches gekennzeichnet, verwendet oder falsch etikettiert werden.
Prostamax, 20mg
Während der Umstellung unserer Verpackung erhalten Sie möglicherweise Produkte mit dem bisherigen oder dem neuen Etikett. Formulierung, Reinheit und Qualität bleiben nach unseren Standards genau gleich.
- Kreditkarte
- Banküberweisung (SEPA Echtzeit)
- Banküberweisung (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Andere
-25% auf alles – bis 31. Oktober
25% auf reguläre Preise statt anderer Angebote. Nur mit dem Krypto-Zahlungsrabatt kombinierbar.
Jede Charge wird auf Reinheit, Wirksamkeit und Qualität geprüft.
Laborergebnisse ansehen →Prostamax is a short peptide bioregulator investigated for its interactions with peptide-mediated regulatory pathways and molecular signaling systems. Experimental studies have examined its activity in transcription-associated processes, chromatin-interaction models, peptide–DNA binding investigations, and signal transduction research.
Its low-molecular-weight peptide structure makes it a useful tool for studies of peptide bioregulator pharmacology, molecular regulatory mechanisms, transcription-associated signaling pathways, and comparative investigations of short regulatory peptide compounds.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C20H33N5O9 |
|---|---|
| Synonyms | SCHEMBL6660498 |
| Molar Mass | 487.5 g/mol |
| PubChem CID | 9848296 |
| Total Compound Content | 20 mg per vial |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What is the proposed mechanism of action of peptide bioregulators such as Prostamax?
A proposed mechanism for short peptide bioregulators involves interactions with chromatin-associated regulatory systems and transcription-related molecular pathways.
Experimental investigations have examined whether short peptide sequences can interact with DNA-protein complexes, influence chromatin architecture, and modulate transcription-associated processes through peptide-mediated molecular recognition mechanisms.
This proposed mode of action remains an active area of investigation and continues to be explored through studies of peptide–DNA interactions, chromatin dynamics, and transcriptional regulation.
How does Prostamax relate to other short peptide bioregulators?
Prostamax belongs to a broader class of short peptide bioregulators that share common characteristics, including low molecular weight, short amino acid sequences, and proposed activity within molecular regulatory systems. Comparative investigations frequently examine differences in peptide sequence composition, chromatin-interaction profiles, signaling pathway modulation, and transcription-associated effects to better understand structure-activity relationships across this class of compounds.
What experimental evidence has been reported for Prostamax's molecular activity?
Published investigations have reported effects on transcription-associated processes, peptide-mediated regulatory pathways, chromatin-interaction models, and molecular signaling mechanisms. These findings have contributed to ongoing research into short peptide bioregulator pharmacology and the proposed role of regulatory peptides in modulating molecular signaling networks.
As with many compounds in this category, further mechanistic investigation and independent validation remain important areas of continued research.
